Forest Laboratories et al v. Amerigen Pharmaceuticals Inc. et al > Summary
Court Case Number 1:14-cv-01271
Filing Date Oct 3, 2014
Termination Date Oct 23, 2015
Court Delaware District Court
Status Unknown
Defendant
Plaintiff Attorneys
6Allergan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Supernus Pharmaceuticals
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Defendant Attorneys
2Counter Defendant
6Allergan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Supernus Pharmaceuticals
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Counter Claimant
2Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08598233 | Method for administering an NMDA receptor antagonist to a subject | Dec 3, 2013 |
| 08362085 | Method for administering an NMDA receptor antagonist to a subject | Jan 29, 2013 |
| 08329752 | Composition for administering an NMDA receptor antagonist to a subject | Dec 11, 2012 |
| 08283379 | Methods and compositions for the treatment of CNS-related conditions | Oct 9, 2012 |
| 08173708 | Method and composition for administering an NMDA receptor antagonist to a subject | May 8, 2012 |
| 08168209 | Method and composition for administering an NMDA receptor antagonist to a subject | May 1, 2012 |
| 08039009 | Modified release formulations of memantine oral dosage forms | Oct 18, 2011 |
